Navigation Links
GDS International Leads the Way for the Pharmaceutical Industry at its Upcoming NGP DD 30 Summit in Madrid
Date:6/12/2013

MADRID, June 12, 2013 /PRNewswire/ --

On 9th - 11th September, a selection of the region's most prominent C-level executives from across the pharmaceutical industry will convene at the Sheraton Mirasierra Hotel & Spa, Madrid at GDS International's fifth European Next Generation Pharmaceutical Drug Discovery Summit.

This year NGP DD 30 has elected 30 of the most well-respected decision makers from the pharmaceutical sector to meet, network, and assess the rapidly evolving industry in a vibrant, closed door environment at the 2.5 day event.

The exclusive location, the intimate number of delegates and the outstanding content offer the executives an ideal structure for new business relationships to grow. The series of interactive workshops and moderated peer-led panel discussions give delegates the opportunity to meet with business analysts and solution providers to determine strategies and solutions for the year ahead.

Included within this year's delegation are Sibo de Jong, Vice-President Pharmaceutical R&D, Astellas; Simon Read, Vice President & Head of Global Biomedical Sciences, Andreas Schneider, VP Life Science Alliances, Roche; Michael Rotte, Biomarker Development EU Head, Novartis; Dave Gunput, Head of Translational Medicine & Exploratory Development, Mitsubishi Pharmaceutical.

The industry is facing its biggest ever challenges. With the help of all involved the summit will highlight the most relevant areas in today's market. Topics to be discussed at this year's summit include; Personalizing Medicine, Slip Streaming the R&D Process & Reducing Late Stage Attrition.

Bjorn Mellgard, Glo
'/>"/>

SOURCE GDS International
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. RSB Spine, LLC, Announces International Distribution and Licensing Agreement
2. PAREXEL International To Present At William Blair Growth Stock Conference And Goldman Sachs Healthcare Conference
3. MEDIFIRST SOLUTIONS, INC. To Exhibit At The Orlando International Beauty Show
4. DMH International Announces EMR Integration to TouchPACS
5. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
6. Israel Brain Technologies Announces Israels 1st International Brain Technology Conference
7. Clinical Team Researching the Impact of the EarlySense System Wins Best Novel Idea Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference
8. PAREXEL International To Present At Jefferies Healthcare Conference
9. Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis
10. IsoRay Announces A New International Distributor For Greece
11. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20, 2014 Norgine B.V. today ... low volume bowel preparation, NER1006, presented at the 79 ... of Gastroenterology (ACG), Philadelphia, PA , ... weight and co-primary endpoint of cleansing success. The study ... MOVIPREP ® in screening colonoscopy patients. [1] ...
(Date:10/19/2014)... SEATTLE, Wash. , Oct. 20, 2014 ... today that it will report its third quarter 2014 ... close of the U.S. financial markets. Following the announcement, ... conference call to discuss the results and provide a ... PDT). Access to the event can be obtained as ...
(Date:10/18/2014)... , Oct. 18, 2014  In a ... Campaign (HRC), the nation,s largest lesbian, gay, bisexual ... the use of Truvada for Pre-Exposure Prophylaxis (PrEP). ... used to prevent the spread of a disease ... only brand name anti-HIV drug combination currently approved ...
Breaking Medicine Technology:Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3
... MONTREAL, May 3, 2012 , 2012 First ... of certain dermatology assets , Pro forma organic growth ... and acquisitions, was approximately 11% , 2012 First ... Excluding impact from dermatology divestiture, Cash EPS was $0.99 ...
... SAN DIEGO, May 3, 2012 Optimer Pharmaceuticals, Inc. ... Company will present at the Bank of America Merrill ... AM Pacific Time in Las Vegas, NV. ... webcast of the presentation will be accessible on the ...
Cached Medicine Technology:Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 2Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 3Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 4Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 5Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 6Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 7Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 8Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 9Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 10Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 11Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 12Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 13Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 14Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 15Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results 16
(Date:10/20/2014)... WA (PRWEB) October 20, 2014 My ... workflow management software application. The new module enables ... patients receive full life-cycle quality care. , This application ... others within their practice, attach a to-do item to ... fit, and even set up reoccurring reminders for follow-ups. ...
(Date:10/20/2014)... 20, 2014 Myoderm ... Assistant Director of their CentralSource service. ... the innovative turnkey drug sourcing, distribution, and management ... over 12 years of industry experience, in both ... the peak of their international success to help ...
(Date:10/20/2014)... Fort Collins, CO (PRWEB) October 20, 2014 ... platform, dGH assays are the only imaging assays ... data in a single test.  With these three ... in their ability to detect the widest range ... chromosomal translocations—mutations usually missed by other genomic tools, ...
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Unveiled at ... new Strategic Direction Scorecard conservatively estimates member hospital ROI on ... spent on dues, The Center provides $12.50 in value to ... is (Member Value – Member Dues)/Member Dues. , “This ... at this number and we think the methodology is really ...
(Date:10/20/2014)... Houston plastic surgeon Dr. Christopher Patronella ... his innovative True Form Tummy Tuck® method ... faculty at The University of Texas Medical Branch ... a medical student. Patronella, who is a founding partner ... practices in Texas, The Aesthetic Center for Plastic ...
Breaking Medicine News(10 mins):Health News:My Clients Plus Announces New Workflow Management Software 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2
... Lancet Medical Journal reports that vaccination against the sexually transmitted ... girls in Europe//. ,All the girls of the ... of GlaxoSmithKline or with Gardasil of Merck & Co., according ... one in the U.S. in which, a bill passed by ...
... long lasting modifications in the brain metabolism and blood ... and confusion in several cancer survivors. , ... California, Los Angeles, revealed inferior metabolism in the important ... undergone chemotherapy 5-10 years ago.,A spike in blood flow ...
... declared ENBRELR (etanercept) safe to be used to treat psoriasis ... The result of the current studies were presented at the ... is a 'Biologic Medicine which means it is synthesized using ... principles of biotechnology. , , ,This biologic medicine ...
... cancer, such as radiotherapy, surgery and drugs as well ... vary throughout the EU, according to a study published ... 3 October 2006. Access to information is also said ... survey published in Medical OncologyStatus in Europe is a ...
... cause bone loss in older women is likely to ... India//, already caught in a controversy over higher than ... ,American epidemiologists have reported that colas are associated with ... osteoporosis risk for older women. Osteoporosis is a disease ...
... are experiencing unjust dismissal and discrimination at work place ... rights//. ,The Disability Discrimination Act came into ... effective protection at work to people with severe illnesses ... (DRC) has reported that 200 cancer patients had called ...
Cached Medicine News:Health News:Chemotherapy causes mental fog 2Health News:Enbrelr Enters Safer Zone After Recent Research 2Health News:Colas can cause bone loss in old women 2Health News:Injustice to cancer patients at work 2
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: